Arrowhead Pharmaceuticals
Price & Volume
Stats
See more52W Range | $14.30-$82.26 |
Market Cap | $11.1B |
Shares Short | 12M |
Financials
See moreRevenue (12 Mos) | $622M |
Revenue Growth (YoY) | -86.4% |
Gross Profit (12 Mos) | $622M |
Diluted EPS | -$2.27 |
News
See moreYahoo Finance • 27 days ago
Arrowhead (ARWR) Rated Buy on Metabolic Pipeline Potential
Yahoo Finance • 29 days ago
Complement Inhibitors Market Outlook Remains Strong During the Forecast Period (2026–2036) with Increasing Adoption of C5 and C3 Targeted Drugs | DelveInsight
Yahoo Finance • last month
Stocks Erase Early Gains as Crude Prices Jump on Iran Concerns
Yahoo Finance • 3 months ago
Arrowhead (ARWR) FQ1 2026 Revenue Hits $264M as REDEMPLO Approval Marks Commercial Shift
About
CEO | Dr. Christopher R. Anzalone Ph.D. |
Address | 177 East Colorado Boulevard, Pasadena, CA, United States, 91105 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 711 |